DX-8951f: summary of phase I clinical trials.
De Jager R, Cheverton P, Tamanoi K, Coyle J, Ducharme M, Sakamoto N, Satomi M, Suzuki M; DX-8931f Investigators.
De Jager R, et al.
Ann N Y Acad Sci. 2000;922:260-73. doi: 10.1111/j.1749-6632.2000.tb07044.x.
Ann N Y Acad Sci. 2000.
PMID: 11193901
Review.